1 GABAPENTIN | 90 of 5410 | 3860 prescriptions Less than 1% of all prescriptions | 2490 | 910 patients 31% of all patients | 600 patients 20% of all patients | |
2 OXYCODONE HCL | 110 of 2980 | 4370 prescriptions Less than 1% of all prescriptions | 2800 | 670 patients 23% of all patients | 430 patients 14% of all patients | O |
3 HYDROCODONE-ACETAMINOPHEN (HYDROCODONE/ACETAMINOPHEN) | 150 of 6660 | 4440 prescriptions Less than 1% of all prescriptions | 3010 | 810 patients 27% of all patients | 560 patients 19% of all patients | O |
4 OXYCODONE-ACETAMINOPHEN (OXYCODONE HCL/ACETAMINOPHEN) | 130 of 4190 | 3390 prescriptions Less than 1% of all prescriptions | 2900 | 470 patients 16% of all patients | < 11 | O |
5 TIZANIDINE HCL | 180 of 1710 | 1130 prescriptions Less than 1% of all prescriptions | 460 | 340 patients 11% of all patients | 130 patients 4% of all patients | |
6 TRAMADOL HCL | 180 of 5370 | 1320 prescriptions Less than 1% of all prescriptions | 1030 | 290 patients 10% of all patients | < 11 | O |
7 LYRICA (PREGABALIN) | 170 of 1650 | 920 prescriptions Less than 1% of all prescriptions | 560 | 220 patients 7% of all patients | < 11 | |
8 CYCLOBENZAPRINE HCL | 250 of 3110 | 640 prescriptions Less than 1% of all prescriptions | 370 | 190 patients 6% of all patients | < 11 | |
9 OXYCONTIN (OXYCODONE HCL) | 180 of 710 | 700 prescriptions Less than 1% of all prescriptions | 520 | 110 patients 4% of all patients | < 11 | O |
10 DULOXETINE HCL | 510 of 2580 | 400 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | |
11 DICLOFENAC SODIUM | 330 of 3460 | 510 prescriptions Less than 1% of all prescriptions | 390 | 280 patients 9% of all patients | < 11 | |
12 MELOXICAM | 540 of 3460 | 530 prescriptions Less than 1% of all prescriptions | 420 | 180 patients 6% of all patients | < 11 | |
13 BUPRENORPHINE | 20 of 140 | 490 prescriptions Less than 1% of all prescriptions | 190 | 120 patients 4% of all patients | < 11 | O |
14 MORPHINE SULFATE | 120 of 480 | 500 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | O |
15 MORPHINE SULFATE ER (MORPHINE SULFATE) | 370 of 880 | 420 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | O |
16 AMITIZA (LUBIPROSTONE) | 80 of 460 | 320 prescriptions Less than 1% of all prescriptions | | 110 patients 4% of all patients | < 11 | |
17 EMBEDA (MORPHINE SULFATE/NALTREXONE) | 30 of 160 | 320 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | O |
18 TRAMADOL HCL ER (TRAMADOL HCL) | 30 of 250 | 290 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | O |
19 BUTRANS (BUPRENORPHINE) | 80 of 220 | 300 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | O |
20 XTAMPZA ER (OXYCODONE MYRISTATE) | 120 of 280 | 270 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | O |
21 HYDROCODONE-IBUPROFEN (HYDROCODONE/IBUPROFEN) | 20 of 60 | 250 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | O |
22 VOLTAREN (DICLOFENAC SODIUM) | 70 of 660 | 310 prescriptions Less than 1% of all prescriptions | | 150 patients 5% of all patients | < 11 | |
23 BACLOFEN | 400 of 1320 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 BELBUCA (BUPRENORPHINE HCL) | 60 of 120 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | O |
25 LIDOCAINE | 90 of 330 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 MOVANTIK (NALOXEGOL OXALATE) | 60 of 170 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 METHOCARBAMOL | 130 of 490 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 SYMPROIC (NALDEMEDINE TOSYLATE) | 40 of 70 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
29 ORPHENADRINE CITRATE ER (ORPHENADRINE CITRATE) | 60 of 90 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
30 NARCAN (NALOXONE HCL) | 170 of 460 | 160 prescriptions Less than 1% of all prescriptions | | 160 patients 5% of all patients | < 11 | |